SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 1, 2002
AETNA INC.
(Exact Name of Registrant as Specified in its Charter)
Pennsylvania 1-16095 23-2229683
(State or Other Jurisdiction (Commission File Number) (I.R.S. Employer
of Incorporation Identification No.)
151 Farmington Avenue
Hartford, Connecticut 06156
(Address of Principal Executive Offices) (Zip Code)
(860) 273-0123
(Registrant's telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events and Regulation FD Disclosure
The Board of Directors (the "Board") of Aetna Inc. (the "Company") has
authorized the repurchase of up to 5 million shares of common stock (not to
exceed an aggregate purchase price of $200 million), subject to periodic
reauthorization by the Board. The Company repurchased 2,600,000 shares of
common stock at a cost of approximately $96 million during the first quarter of
2001 pursuant to this authorization and ceased such repurchases at the end of
the first quarter of 2001. The Company has re-initiated share repurchases
pursuant to this authorization. The Company repurchases shares in the open
market, primarily to seek to mitigate dilution resulting from employee stock
option exercises, and generally funds these repurchases by using net proceeds
available from stock option exercises.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AETNA INC.
Date: May 1, 2002 By: /s/ Ronald M. Olejniczak
----------------------------
Name: Ronald M. Olejniczak
Title: Vice President and
Controller